BioChemics (BCI) has developed a novel, transdermal drug delivery system called Vale (vaso-active lipid encapsulated), that allows a wide variety of actives to be delivered into the skin.
John Masiz, president of BioChemics, said: “We are delighted to be working with Cynosure to evaluate broader applications of our Vale based technology for light based procedures.”